Cargando…
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
Cell death plays a pivotal role in the maintenance of tissue homeostasis. Key players in the controlled induction of cell death are the Death Receptors (DR). CD95 is a prototypic DR activated by its cognate ligand CD95L triggering programmed cell death. As a consequence, alterations in the CD95/CD95...
Autores principales: | Risso, Vesna, Lafont, Elodie, Le Gallo, Matthieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931059/ https://www.ncbi.nlm.nih.gov/pubmed/35301281 http://dx.doi.org/10.1038/s41419-022-04688-x |
Ejemplares similares
-
The CD95/CD95L Signaling Pathway: A Role in Carcinogenesis
por: Fouqué, Amélie, et al.
Publicado: (2014) -
The CD95/CD95L Signaling Pathway: A Role in Carcinogenesis
por: Fouqué, Amélie, et al.
Publicado: (2020) -
The dual role of the CD95 and CD95L signaling pathway in glioblastoma
por: Zhang, Yanrui, et al.
Publicado: (2022) -
CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
por: Le Gallo, Matthieu, et al.
Publicado: (2017) -
The role of CD95 and CD95 ligand in cancer
por: Peter, M E, et al.
Publicado: (2015)